Rezonate's Kira™ Now a Qualified Solution on the Mayo Clinic Platform
Rezonate, a prominent healthcare artificial intelligence company, has proudly announced that its flagship product, Kira™, has achieved qualification on the prestigious Mayo Clinic Platform. This collaboration marks a significant milestone for Rezonate, known previously as KeyReply, which has been delivering top-notch patient and staff engagement solutions throughout Asia for over a decade.
What is Kira™?
Kira™ is an advanced omnichannel AI assistant designed to streamline communications in healthcare settings. It operates across a variety of platforms, including chat, voice, SMS, WhatsApp, email, and Microsoft Teams, making it a versatile tool for healthcare providers. By automating patient engagement and staff interactions, Kira™ significantly improves service efficiency and patient satisfaction.
The application is engineered to handle high-volume workflows, ensuring that healthcare organizations can manage scheduling, outreach, and internal support tasks effectively. Key features of Kira™ include:
- - Appointment Management: Streamlining booking and rescheduling of appointments.
- - Patient Reminders: Automated alerts to mitigate missed appointments.
- - Multilingual Support: Catering to diverse patient populations by offering assistance in over 60 languages.
- - Clinical Governance: Built-in safeguards to maintain compliance and safety throughout interactions.
By providing timely updates and facilitating easy access to care resources, Kira™ enhances the patient experience from pre-appointment counseling to post-discharge follow-up activities.
Impact of Kira™ in Healthcare
Since its launch, Kira™ has successfully managed more than 83 million AI interactions, including over 12 million healthcare inquiries each year. These interactions are not only limited to basic queries; they also encompass complex patient navigation tasks, demonstrating Kira™’s capability to integrate seamlessly into the healthcare workflow.
Remarkably, Kira™ has proven to increase customer engagement rates from a mere 20% on traditional platforms to an impressive 90% with its omnichannel functionality. This leap indicates that patients are thriving with the accessibility and responsiveness afforded by this platform.
Collaborative Development with Mayo Clinic
Rezonate's partnership with the Mayo Clinic Platform Solutions Studio played a crucial role in the development and validation of Kira™. This program aims to support developers of digital health solutions by providing an ecosystem that nurtures innovation and facilitates real-world application of digital health technologies. Each product is rigorously assessed for its intended use and clinical performance, ensuring that only solutions adhering to responsible AI practices are validated.
Steve Bethke, Vice President at Mayo Clinic Platform, emphasized the importance of integrating innovative solutions, stating, "When a solution is on Mayo Clinic Platform and qualified, providers can trust it has been reviewed for adherence to responsible AI principles, all aimed at supporting care teams and improving patient outcomes."
The Future of Healthcare with AI
As healthcare organizations grapple with rising demands for efficient patient care, the adoption of AI technologies like Kira™ becomes crucial. Rezonate's CEO, Peiru Teo, expressed the company's commitment to facilitating responsible AI adoption, which not only enhances patient engagement but also boosts operational efficiency for healthcare providers.
Kira™ is indicative of a transformative shift in how healthcare engages with patients, moving away from traditional transactional models towards a more integrated and responsive care paradigm.
In summary, Rezonate’s Kira™ stands out as a qualified solution on the Mayo Clinic Platform, showcasing the potential of AI to revolutionize patient engagement and streamline hospital workflows. As these technologies evolve, they will undoubtedly play a key role in shaping the future of healthcare delivery, ultimately improving outcomes for patients and providers alike.